U.S. 503B Compounding Pharmacies Market Worth US$ 866.3 Mn Get Deep Data Analysis by Our Experts
Utilizing both primary and secondary research methods, Reports and Insights investigated the U.S. 503B Compounding Pharmacies Market from every perspective in recent times. The issued report is promising the clients to help them gain a deeper understanding of prevailing market dynamics such as supply-demand asymmetry, product preferences, customer preferences and habits, pricing trends, and so forth. The data is then compiled and evaluated using a scale of market assessment and data validation approaches. In addition, Reports and Insights have an in-house data prognostic approach that prophecies market growth through 2031.
503B Compounding Pharmacies Market Overview
The report is titled as ‘ U.S. 503B Compounding Pharmacies Market: Opportunity Analysis and Future Assessment 2023-2031’. An overview of conceptual frameworks, analytical approaches of the 503B Compounding Pharmacies market is the main objective of the report, which further consists the market opportunity and insights of the data involved in the making of the respective market. 503B Compounding Pharmacies market is expected to grow with significant rate in the near future.
In 2020, U.S. 503B Compounding Pharmacies market was valued at US$ 866.3 Mn and expected to grow significantly at a CAGR of 7.3% over the forecast period
Get a Sample Copy of this Report with Graphs and Charts
Introduction
In the sphere of pharmacy, compounding can refer to the formulation of a custom compound or mixture of a medication to correspond to a special need of a patient that cannot be achieved with commercially available products. To quote the instance offered by Linda D. Bentley, JD, chair of the FDA practice group, a person is likely to be sensitized to one of the constituents in the commercial form of a drug. In such instances, a compounding pharmacy carried the capacity to make the appropriate form and dosage of the drug without any provoking constituents.
Given the fact that regulators have undertaken assigning higher scrutiny on compounding pharmacies subsequent incidents related to poor inadvertence by state boards of pharmacy, FDA has categorized these pharmacies into two segments: 503A and 503B. The FDA has specified 503B compounding pharmacies as those including outsourcing facilities that have the capability to generate large batches with or without prescriptions to put up for sale to healthcare facilities only for office use. Moreover, these pharmacies also possess the authority to use larger batches to lessen their manufacturing costs, shifting the savings over consumers.
Market Dynamics
In the present items, the growing prevalence of chronic diseases as well as growing geriatric population is majorly causing the increased drug shortage all around the world, ultimately boosting the demand of compounding pharmacies. To support that, as per the report by the U.S. Food and Drug Administration (FDA): Drug Shortages: Root Causes and Potential Solutions 2019, about 36.6% hospitals exclaimed that they had rescheduled non-urgent or emergent procedures and 56% of hospitals stated they had made amends in patient care or delayed therapy taking into account drug shortages. Owing to which, the 503B compounding pharmacies market is projected to rise significantly in the following years.
In addition to that, the U.S. FDA further published guidelines according to which the FDA will not be taking any action against outsourcing facilities. These regulations comprise conditions such as outsourcing facilities manufacturing compounding drugs that is largely a replicate of a certified drug. Such factors are further projected to propel the growth of the 503B compounding pharmacies market over the forecast period.
Furthermore, the leading players of the market are heavily engaged in organic activities such as partnerships and new product launches in order to overpower the increasing drug shortage problems. For instance, Piramal Critical Care (PCC), in July 2020, joined hands with Medivant Healthcare, a U.S. based pharmaceutical outsourcing facility, in the form of strategic partnership in order to address the serious shortage of injectable drugs in hospitals all across the United States. Attributing to such factors, the 503B compounding pharmacies market is expected to witness considerable growth in the coming years.
Reports & Insights Overview
The non-identical approach of Reports and Insights stands with conceptual methods backed up with the data analysis. The novel market understanding approach makes up the standard of the assessment results that give better opportunity for the customers to put their effort.
A research report on the 503B Compounding Pharmacies market by Reports and Insights is an in-depth and extensive study of the market based on the necessary data crunching and statistical analysis. It provides a brief view of the dynamics flowing through the market, which includes the factors that supports market and the factors that are acting as impedance for the growth of the market. Furthermore, the report includes the various trends and opportunities in the respective market in different regions for a better understanding of readers that helps to analyze the potential of the market.
Some of the key questions answered in this report:
- Which are the five top players of the U.S. 503B Compounding Pharmacies Market?
- How will the U.S. 503B Compounding Pharmacies Market change in the upcoming years?
- Which product and application will take a share of the U.S. 503B Compounding Pharmacies Market?
- What are the drivers and restraints of the U.S. 503B Compounding Pharmacies Market?
- Which regional market will show the highest growth?
- What will be the CAGR and size of the U.S. 503B Compounding Pharmacies Market throughout the forecast period?
- What is the current market size, what will the market size be in 2031 and what will the growth rate be?
- What are the challenges to grow in the market?
- What are the market opportunities and challenges faced by the key vendors?
- Who are the major competitors and what is their strategy?
- What are the barriers to entry for new players in the market?
- What is S. 503B Compounding Pharmacies Market?
- S. 503B Compounding Pharmacies Market size in USA
503B Compounding Pharmacies Market Segmentation
The U.S. 503B Compounding Pharmacies market is segmented on the basis of molecule, packaging, and compounding type
By Molecule
- Acetaminophen
- Phenylephrine
- Midazolam
- Esmolol
- Vancomycin
- Epinephrine
- Adenocaine
- Fentanyl/Bupivacaine
- Morphine
- Amiodarone
- Heparin
- Ketamine
- Dextrose
- Hydromorphone
- Bupivacaine
- Lidocaine
- BKK (Bupivacaine, Ketorolac, and Ketamine)
- RCK (Ropivacaine, Clonidine, and Ketorolac)
- RKK (Ropivacaine, Ketorolac, and Ketamine)
- Other Molecules
By Packaging
- Vials
- Prefilled Syringes
- Ampoules
- Syringes
- Others
By Compounding Type
- Hormone Replacement Therapy (HRT)
- Men’s Health Compounding
- Pain Management Compounding
- Pediatric Compounding
- Veterinary Compounding
- Geriatric Compounding
503B Compounding Pharmacies Market Key Players
Some of the key participating players in U.S. 503B Compounding Pharmacies market are:
- Central Admixture Pharmacy Services, Inc.
- Nephron Pharmaceuticals Corporation
- QuVa Pharma
- Olympia Pharmacy
- ASP Cares
- Fagron Compounding Pharmacies
- Athenex, Inc.
- Avella Specialty Pharmacy
- Atlas Pharmaceuticals
- Empower Pharmacy
- Carie Boyd’S Prescription Shop
- Edge Pharma
- Imprimis NJOF, LLC
- IntegraDose Compounding services, LLC
- Wells Pharma of Houston, LLC
- US Compounding Inc.
- SCA Pharma
To view Top Players, Segmentation and other Statistics of U.S. 503B Compounding Pharmacies Market, Get customization Report @: https://reportsandinsights.com/free-customization/6814
About Reports and Insights:
Reports and Insights is one of the leading market research company which offers syndicate and consulting research around the globe. At Reports and Insights we adhere to the client needs and regularly ponder to bring out more valuable and real outcomes for our customers. We are equipped with strategically enhanced group of researchers and analysts that redefines and stabilizes the business polarity in different categorical dimensions of the market.
Contact Us:
Reports and Insights
Tel: +1-(718)-312-8686
For Sales Query: sales@reportsandinsights.com
For New Topics & Other Info, Visit: reportsandinsights.com/
Website: https://reportsandinsights.com
This Press Release has been written with the intention of providing accurate market information which will enable our readers to make informed strategic investment decisions. If you notice any problem with this content, please feel free to reach us on mediarelations@xherald.com.
Xherald
